Huntington’s disease is an inherited disorder that leads to the degeneration of certain nerve cells in the brain. There is currently no treatment or drugs to slow down the progression of the disease. Dr. Albert La Spada, director of the Duke Center for Neurodegeneration and Neurotherapeutics, has been working on this disease and their newest discover is exploring the use of bexarotene, a cancer treatment for advanced lymphomas, as a therapy for Huntington’s. To read more about the discovery and how it can change the future of the disease, click here.